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Abstract 
 
Data Envelopment analysis of the health care delivery system of G12 nations is presented here.  
Japan and Spain scored the highest and the US, the lowest level of relative efficiencies. 
Health care outputs are life expectancy and infant mortality.  Inputs are per capita health care 
expenditure; population adjusted physicians, hospital beds, and MRI; and a proxy for the level of 
education.  DEA tests are applied for the 1991-1995 period using both CCR and BCC models.  
The paper argues that the lack of universal health care coverage and a single payer system are 
among the problems that the United States needs to address in order to improve its health care 
delivery.  
 
 
1.0  Introduction 
 
ignificant increases in health care costs have been burdening national economies for a number of years.  
This problem is of particular concern to industrialized countries where support for vital services, such as, 
national security and education are gaining more public demand.  In 1984, OECD countries had a health 
care per capita expenditure mean of $870.00 (with purchasing power parity adjustment); this figure rose to 
$1,983.00 in 2000.  When compared with the OECD means, the United States has maintained two times its per 
capita expenditure in the past 20 years.  While controlling costs is the priority, both developed and developing 
nations are trying to improve access to and quality of health care services for their citizens. 
 
The majority of research in the area of efficiency measurement has focused on the firm/organizational 
level.  In the health care sector, as increasingly more resources are poured in, it is equally important to know the 
relative efficiency of the entire (macro) system.  However, an important aspect of macro-level analysis is to have 
input and output measures that are consistent, definable and uniform across different systems.  
 
Among the various methods of efficiency assessment, researchers in the field of business management have 
frequently used Data Envelopment Analysis (DEA).  The robustness of DEA has been the main reason for its wide 
popularity.  Although there are published studies related to a comparative analysis of health care systems, none, at 
the time of writing this paper, have applied the DEA method in assessing macro-level efficiencies. 
 
The objective of this paper is to apply the DEA technique to the measurement of health care efficiencies of 
G12 countries and discuss policy implications of such findings.  The organization of the paper is as follows:  First, a 
review of literature is provided.  Next, the DEA methodology is elaborated upon and is followed by empirical 
testing and analysis.  The last part of the paper will be devoted to the summary and conclusions. 
 
2.  Literature Review 
In a comparative analysis of health care systems, we have found a number of fairly recent studies.  In a five 
nation (New Zealand, UK, US, Canada, and Australia) study, Blendon et. al. (2003) finds that a significant number 
of citizens are dissatisfied with their health care system.  With a focus on OECD countries, Anell and Willis (2000) 
suggest that instead of expenditure measures, using a resource profile is a more desirable alternative for an 
international comparison of health care systems.  In another OECD-based study, Anderson, et. al. (2003) suggest 
S 
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that differences in health care spending patterns between the United States and the rest of the member nations are 
mostly explained by higher prices in the US.  With a sampling of 191 countries worldwide, Evans et al. (2001) 
applied the regression technique to conduct a comparative efficiency of national health care systems.  Using life 
expectancy as health output and health expenditures and average schooling as inputs, they conclude that while 
increased resources result in improved health, a more efficient use of resources can also contribute to the overall 
health care of a nation. 
 
As mentioned earlier, a large majority of DEA studies focus on micro-level applications; very few on 
macro-level applications.  For example, Dimelis and Dimopoulou (2002) use DEA to evaluate the productivity 
growth of countries in the European Union.  They suggest that because DEA does not impose any constraints, it 
“frees” the user from assigning a priori assumptions about weights used in the model.  In another study, Cherchye 
(2001) applies DEA to assess macroeconomic policy performance of OECD countries.  Here also, DEA’s robustness 
and its ability to allow researchers to assess the relative rankings of the observed decision making units, (countries) 
are the motivation for its application. 
 
Within the health care sector, DEA has gained much popularity in the 1990’s. Hollingsworth et. al (1999) 
provides a thorough review of various applications.  More recent applications of DEA to hospital efficiency 
measurement can be found in Hofmarcher et. al. (2002), Giokas (2002), and Bhat (2001) that also elaborates on its 
extensions, strengths and limitations.  DEA’s comparison with regression analysis is applied to the managed care 
organization by Nyhan and Cruise, (2000) and to primary care by Giuffrida and Gravelle (2001).  
 
3.  DEA Model 
 
DEA is a linear programming tool that is primarily used to estimate the optimal combinations of inputs and 
outputs to construct an efficiency frontier.  In other words, technical efficiency in DEA is characterized by the 
frontier (isoquant) that shows the lowest input used to achieve a given level of output.  The frontier is based on 
actual observations from organizations, known as decision-making units (DMUs). DEA calculates the efficiency of 
a given system or organization relative to the best performing DMU.  A DMU is considered technically inefficient if 
it lies below the frontier.  Those on the frontier are, of course, the efficient systems. 
 
Theoretical advantages and disadvantages of the DEA technique as compared to other techniques (for 
example, the regression technique) as well as a wide range of DEA applications have been summarized and 
evaluated by Seiford (1996) and Berger et. al. (1997).  A common thread in most of the studies that have chosen 
DEA as their preferred method is due to its less restrictive nature.  Furthermore, its ability to perform reliably, with 
accurate results, when a small sample of observations is present, is highlighted in Smith (1997). 
 
The theoretical framework of DEA was first introduced in a seminal study by Charnes et. al. (1978).  This 
study extended the single-output-input technical efficiency measure (pioneered by Farrell, 1957), to a multiple 
output-input relative efficiency measures.  Since then, a number of variations and extensions of the original model 
and software development have been introduced.  See, for example, Cooper, et. al. (2000) and Thanassoulis (2001).  
 
An important consideration of the DEA model involves the scale by which a DMU is operating.  If constant 
return to scale is assumed, the size of the DMU will not be relevant in the calculation of relative efficiency 
measures.  In another words, a small health care system can produce an output with the same input-output ratio as a 
large system can.  This is known as the Charnes-Cooper-Rhodes (CCR) model.  However, there exists a possibility 
that a system will have increasing returns to scale; for example, one unit of input resulting in more than one unit of 
output.  It is also possible to have decreasing returns to scale; for example, one unit of input resulting in less than 
one unit of output.  Under such circumstances, an alternative/extension of DEA, known as Banker-Charnes-Cooper 
(BCC) model, is the appropriate method to assess relative efficiencies.  
 
A graphical illustration of the CCR and BCC production frontiers are depicted in Figures 1 and 2.   
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Figure 1- Production Frontier of The CCR Model
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In these diagrams, for simplicity in comparison of the two models, we are showing the case for one input 
and one output.  In each figure, the points C, and E represent those DMUs that are efficient, while points A, B, and 
D are those systems that are deemed to be relatively inefficient. 
 
 
Figure 2- Production Frontier of The BCC Model
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The formulation of the general DEA model is depicted below.  The objective is to maximize output subject 
to resource constraints.  There are K systems (DMUs) to compare their efficiencies, each with a set of Y outputs 
(Yrk) and a set of X inputs (Xik).  The efficiency parameter (Ek) is determined by solving a set of linear programming 
equations, one for each system (DMU).  
  
                              g                  f     
Maximize:  Ek  =  ( Σ  urYrk ) / ( Σ  vi Xik ) ; 
                              r =1             i =1 
 
Subject to:  Ek  ≤ 1,  k = 1, … n ;    
  ur  ≥ 0 ; 
  vi  ≥ 0 ; 
where:  Yrk  is the rth. output from the kth. DMU; 
  Xik   is the ith. intput used by the kth. DMU; 
u and v are the weights generated from the model; g and f are the number outputs (2) and inputs 
(5) respectively; 
Ek  is the ratio of weighted outputs to weighted inputs, the weights are selected in a way that makes 
DMUk as efficient as possible relative to all other DMUs. 
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The basic DEA (as delineated) poses no other constraints other than the ones shown above.  This provides 
us with the highest relative ratings within the DEA framework and thus, the user is not obligated to pre-assign 
relative weights.  The program identifies one or a group of systems that are performing optimally.  Such systems are 
assigned a score of “1” (one) and the rest are scored less than ”1” (one).  The efficiency frontier or “data envelope” 
is created on the basis of the DMU(s) that are receiving the score of “1” (one). 
 
4.  Empirical Test and Analysis 
 
There are two main factors in determining the choices of variables used in the study, namely, consistency 
of measurement among G12 (in reality, there are thirteen members in the so call “G12”) countries, and the 
availability of data across the board.  The period of investigation is 1991-1995.  The majority of data is extracted 
from the OECD, 2000 Report.  When missing data was present, other (mainly internet) sources, were used, a list of 
which is attached as appendix “A”. 
 
Output variables are the average (male and female) life expectancy and infant mortality rates.  As 
evidenced by most of the previous health care related studies, these are two commonly reported macro/national 
health care outcomes.  For inputs, it is our intention to include variables, or, if not directly available, proxies, for 
financial, physical, technological and social factors that will influence health care outcomes in a nation.  Therefore, 
those inputs that are incorporated in this study are: per capita health care expenditure in US dollar and adjusted for 
purchasing power parity, number of inpatient hospital beds per thousand population, number of physicians per 
thousand population, number of magnetic resonance imaging (MRI) per million population and the average school 
life expectancy. 
 
 In performing DEA, first, we focused on direct health care related inputs by omitting average school life 
expectancy.  Both models of DEA, CCR and BCC are applied, efficiency parameters are measured and the ranking 
of member countries are tabulated.  A country with a rank of “1” represents the most efficient and “13”, the most 
inefficient.  The results of the models are shown in Tables 1 and 2.    
  
 
Table 1- Efficiency Ranking, CCR Model, Resources Only 
Country 1991 1993 1995 Mean Rank 
 Life Mort. Life Mort. Life Mort. Life Mort. All 
AUS 5 6 6 5 6 7 5.7 6.0 5.8 
BLG 4 8 7 11 8 12 6.3 10.3 8.3 
CAN 11 9 11 12 10 11 10.7 10.7 10.7 
FRA 10 11 9 9 9 5 9.3 8.3 8.8 
GER 9 7 10 7 11 9 10.0 7.7 8.8 
ITA 7 10 5 8 3 6 5.0 8.0 6.5 
JAP 3 1 3 1 4 3 3.3 1.7 2.5 
NET 8 5 8 6 7 8 7.7 6.3 7.0 
SPA 1 2 1 2 1 1 1.0 1.7 1.3 
SWD 6 4 4 3 5 2 5.0 3.0 4.0 
SWS 12 12 12 10 12 10 12.0 10.7 11.3 
GBR 2 3 2 4 2 4 2.0 3.7 2.8 
USA 13 13 13 13 13 13 13.0 13.0 13.0 
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Table 2- Efficiency Ranking, BCC Model, Resources Only 
. Country 1991 1993 1995 Mean Rank 
 Life Mort. Life Mort. Life Mort. Life Mort. All 
AUS 6 9 5 7 7 9 6.0 8.3 7.2 
BLG 11 12 11 12 11 12 11.0 12 11.5 
CAN 3 6 5 10 5 10 4.3 8.7 6.5 
FRA 9 10 7 9 7 4 7.7 7.7 7.7 
GER 12 8 12 6 12 7 12.0 7.0 9.5 
ITA 10 11 8 11 6 11 8.0 11.0 9.5 
JAP 1 1 1 1 1 3 1.0 1.7 1.3 
NET 7 7 10 8 10 8 9.0 7.7 8.3 
SPA 1 1 1 1 1 1 1.0 1.0 1.0 
SWD 4 4 3 3 3 1 3.3 2.7 3.0 
SWS 5 4 4 5 4 5 4.3 4.7 4.5 
GBR 8 3 9 4 9 6 8.7 4.3 6.5 
USA 12 13 13 13 13 13 12.7 13 12.8 
 
 
 Of the thirteen nations included in this test, whether we use constant returns to scale, i.e. CCR model, or 
variable returns to scale, i.e. BCC model, the Untied States ranks as the least efficient system.  This is the case for 
both life expectancy and infant mortality outcomes in each of the three years of observations, as well as the 
respective average rankings for the entire period.  On the other hand, Spain is the most efficient and Japan is 
positioned in a close second rank.  Beyond the top and bottom performers, there are some variations in the rankings 
of other nations when individual outputs (life expectancy and infant mortality) are considered and CCR and BCC 
results are compared.  When combined mean ranking score is observed, the most pronounced change occurred for 
Switzerland when we switch from CCR to BCC.  Switzerland moved from a rank of “11.3” to a rank of “4.5”.  This 
suggests that the scale of their health care system as a whole is an important factor in determining their efficiency 
level.  When we concentrate on life expectancy alone, Canada, Switzerland and Great Britain stand out.  Focusing 
on Mortality rate, only Switzerland, again, shows a significant variation in its ranking. 
  
 Besides direct resources used for health care, other factors such as the level of education, are influential in 
the health outcomes of a nation.  The OECD reports education life expectancy for its members on an annual basis.  
We included such a variable in the next test and the results are shown in Tables 3 and 4.  Since Italy does not report 
the education level, the ranking order is between “1” and “12”.  Also, in 1995, the education factor was missing for 
Spain, thus their mean ranking is based on 1991 and 1993. 
 
 
Table 3- Efficiency Ranking, CCR Model, Resources and Schooling 
Country 1991 1993 1995 Mean Rank 
 Life Mort. Life Mort. Life Mort. Life Mort. All 
AUS 5 6 9 8 5 7 6.3 7.0 6.7 
BLG 9 11 10 11 9 10 9.3 10.7 10.0 
CAN 12 10 12 10 11 9 11.7 9.7 10.7 
FRA 8 9 8 9 6 5 7.3 7.7 7.5 
GER 10 8 7 6 7 6 8.0 6.7 7.3 
JAP 1 1 1 1 1 1 1.0 1.0 1.0 
NET 9 7 5 7 8 8 7.3 7.3 7.3 
SPA 1 2 1 3 NA NA 1.0 2.5 1.8 
SWD 3 3 4 2 3 1 3.3 2.0 2.7 
SWS 6 4 6 4 1 3 4.3 3.7 4.0 
GBR 4 5 6 4 1 3 3.7 4.0 3.8 
USA 11 12 11 12 10 11 10.7 11.7 11.2 
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Table 4- Efficiency Ranking, BCC Model, Resources and Schooling 
Country 1991 1993 1995 Mean Rank 
 Life Mort. Life Mort. Life Mort. Life Mort. All 
AUS 7 9 5 7 6 8 6.0 8.0 7.0 
BLG 10 11 10 11 9 10 9.7 10.7 10.2 
CAN 5 6 5 10 5 9 5.0 8.3 6.7 
FRA 9 10 7 9 6 4 7.3 7.7 7.5 
GER 11 8 11 6 10 6 10.7 6.7 8.7 
JAP 1 1 1 1 1 1 1.0 1.0 1.0 
NET 8 7 9 8 8 7 8.3 7.3 7.8 
SPA 1 1 1 1 NA NA 1.0 1.0 1.0 
SWD 1 1 3 3 3 1 2.3 1.7 2.0 
SWS 6 5 4 5 4 5 4.7 5.0 4.8 
GBR 1 1 8 4 1 1 3.3 2.0 2.7 
USA 11 12 12 12 11 11 11.3 11.7 11.5 
 
 
 Like in previous tests, when we observe the combined mean ranking, once again, the United States 
maintains its position as the least efficient health care system.  Spain and Japan are ranked as number one and 
Sweden takes the second ranked position.  While concentrating on the cross variation of ranks when we switch 
between the two tables, we noticed that Canada and not Switzerland, stands out, as was the case in previous tests. 
Canada moved from a rank of “10.7” to “6.7”.  This move, however, was mostly attributable to the changes that 
occurred in their respective positions in the life expectancy outcome.  One may suggest that the scale of operation in 
Canada’s health care system [as a whole] is an important factor in determining their efficiency position in the group.  
Overall, the cross variation in ranking tends to be less in mortality outcome than in life expectancy. 
 
 Another finding that is not shown in the tables above, relates to the actual efficiency scores that are 
calculated in our test.  We have found that, overall, when we switch from the CCR to BCC model, the variation in 
scores between the countries tend to narrow noticeably.  In addition, it is revealed that within each table variation in 
efficiency scores, between the top and bottom ranked countries, is significantly less in BCC tests than those nations 
in CCR tests.  For example, in Table 1 (CCR test), the efficiency score of Spain (ranked “1”) in 1991 where life 
expectancy is equal to 1.00 and the United States (ranked “13”) where life expectancy is equal 0.296.  In that same 
category, using Table 2 (BCC test), while Spain maintains the score of 1.00, the United States, in a tie with Germany 
(ranked “12”), receives an efficiency score of 0.953.  These results tend to remain consistent for other years and 
tests. 
 
5.  Summary and Conclusions 
 
 While in industrialized countries, such social service provisions as education, defense, national security, 
social security and retirement plans, draw public attention, a significant and continuous rise in health care costs, 
adds more to the social and political tensions among their citizens.  Reform and restructuring are among a few 
policy initiatives that those nations have been trying to implement as a way to control their health care industries.  
 
 Our goal, ultimately, is to add more depth to the debate over which model of heath system should be 
pursued.  Prior to any restructuring or reform occurs, it is crucial to identify, quantitatively, those nations with the 
most efficient health care delivery system.  Our focus is to assess health care system efficiency of G12 countries. 
The Data Envelopment Analysis, a linear programming technique, is the most widely used in assessing the 
efficiency of organizations in both private and public sectors.  However, there are relatively few studies that 
implemented DEA in a macroeconomic environment. 
 
 An important issue when implementing DEA is the assumption related to the scale economies.  For that we 
generated two sets of tests.  One test is run with the assumption of constant returns to scale and the other with 
variable returns to scale.  First, we centered our attention on those resources that directly influence health care 
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outcomes of life expectancy and infant mortality.  Then, we included a proxy for education (education life 
expectancy) as an indirect factor. 
 
 In comparing the ranking order of the countries, in all tests, the United States proved to be the least 
efficient system while Spain and Japan rankings are consistently the most efficient systems.  One can argue that the 
inefficiencies in the United States can be explained by the fact that Americans spend significantly more on their 
health care than any other nation.  Such expenditure is justified on the notion that Americans regard life and its 
quality with high value.  For example, the United Sates spends proportionately more for extending life for 
individuals that are terminally ill, considered to be the very old, cases involving neo-natal care and premature births.  
This argument, although may be true, concentrates on the micro aspects of the health care deliver system and is 
contrary to the focus of this paper. 
 
 What lessons can the United States learn from this?  The answer is certainly not a simple one.  However, 
when we look at the variations in the overall systems among G12 members, there are some rather clear lessons for 
the United States.  In a comparative study of four European nations (all of which are include in G12) and the United 
States, Brown (2003), among many aspects of health care delivery, supports the notion of universal health care 
coverage under a single payer system. 
 
 On the other hand, there is a long-standing theory in economics that attests to efficiency as the natural 
outcome of a market-driven economy.  The renowned economist, Kenneth Arrow (1963), identifies peculiarities of 
the medical care industry and suggests that it should not be analyzed in the same manner as other markets or 
industries are.  Reinhardt (2001) makes reference to the efficiency of health care delivery in the United States over 
the years, and suggests that it has improved between 1977 and 1988.  Also noteworthy, is the fact that an efficient 
allocation of resources may not necessarily mean an equitable distribution of resources, as denoted by Greenberg 
(1988).   
 
6.  References 
 
1. Anderson, Gerald F.; Uwe Reinhardt; Peter Hussey; and Varduhi Petrosyan, “It’s the prices, stupid: Why the 
United States is so different from other countries,” Health Affairs, Vol. 22, No. 3, May/June 2003, p. 86. 
2. Anell, Andres, Michael Willis, “International comparison of health care systems using resource profiles,” 
Bulletin of the World Health Organization, Vol. 78, No. 6, 2000, pp.770-778. 
3. Arrow, Kenneth J. “Uncertainty and the Welfare Economics of Medical Care,” American Economic Review, 
Vol. 53, No.5, 1963, pp. 941-973.  
4. Berger, AN; Brockett, PL; Cooper, WW; and Pastor, JT “New approaches for analyzing and evaluating the 
performance of financial institutions,” European Journal of Operational Research, Vol. 98, 1997, pp. 169-
174. 
5. Bhat, Ramesh “Methodology note: Data Envelopment Analysis (DEA),” Journal of Health Management, 
Vol. 3, No.2, July-December 2001, pp.309-328. 
6. Blendon, Robert J.; C. Schoen; C. DesRoches, R. Osborn, and Kinga Zapert; “Common concerns amid 
diverse systems: Health care experience in five countries,” Health Affairs, Vol. 22, No. 3, May/June 2003, p. 
106.  
7. Brown, Lawrence D., “Comparing health systems in four countries: Lessons for the United States,” American 
Journal of Public Health, Vol. 93, No.1, January 2003, pp.52-57. 
8. Charnes, A; Cooper, WW; Rhodes, E. “Measuring the efficiency of decision making units,” European 
Journal of Operational Research, Vol. 2, 1978, pp. 429-444. 
9. Cherchye, Laurens “Using data envelopment analysis to assess macroeconomic policy performance,” Applied 
Economics, Vol. 33, 2001, pp.407-416. 
10. Cooper, W.W.; L. M. Seiford; and Kaoru Tone, Data Envelopment Analysis: A comprehensive text with 
models, applications, references and DEA-solver software, Kluwer Academic Publishers, 
Boston/Dorecht/London, 2000. 
11. Dimelis, Sophia and Maria Dimopoulou, “Evaluating productivity growth measures in EU,” Economics of 
Planning: 2002, Vol.35, No. 2, 2002, pp.161-181. 
International Business & Economics Research Journal Volume 3, Number 5 
 42 
12. Evans, David B.; Ajay Tandon; Christopher Murray; and Jeremy Lauer, “Comparative efficiency of national 
health systems: cross national econometric analysis,” BMJ, Vol. 323, 11, August 2001, pp. 307-310. 
13. Farrell, M.J. “The measurement of productive efficiency,” Journal of Royal Statistical Society, Vol. 120, A, 
1957, pp.253-281. 
14. Greenberg, Warren, “Introduction,” Journal of Health Policy, Politics and Law, Vol. 13, No.2, 1988, pp.223-
224. 
15. Hollingsworth, Bruce; P.J. Dawson; and N. Maniakadis “Efficiency measurement of health care: a review of 
non-parametric methods and applications,” Health Care Management Science, Vol.2, 1999, pp.161-172. 
16. Giokas, D. “The use of goal programming, regression analysis and data envelopment analysis for estimating 
efficient marginal costs of hospitals,” Journal of Multicriteria Decision Analysis, Vol. 11, Jul-Oct. 2002, pp. 
261-268. 
17. Giuffrida, Antonio, and Hugh Gravelle, “Measuring performance in primary care: econometric analysis and 
DEA,” Applied Economics, Vol. 33, 2001, pp.163-175. 
18. Hofmarcher, Maria M.; Iain Paterson; and Monika Riedel, “Measuring hospital efficiency in Austria - a DEA 
approach,” Health Care Management Science, Vol. 5, No1, February 2002, pp. 7-14. 
19. Nyhan, Ronald C., and Peter Cruise “Comparative performance assessment in managed care: Data 
envelopment analysis for health care managers,” Managed Care Quarterly, Vol. 8, No. 1, 2000, pp. 18-27. 
20. Reinhardt, Uwe E. “Can efficiency in health care be left to the market?” Journal of Health Policy, Politics 
and Law, Vol. 26, No.5, 2001, pp. 967-992. 
21. Seiford, LM “Data Envelopment Analysis: The evaluation of the state of the art (1978-1985),” The Journal of 
Productivity Analysis, Vol. 7, 1996, pp.99-137. 
22. Smith, P. “Model misspecification in Data Envelopment Analysis,” Annals of Operation Research, Vol.73, 
1997, pp. 233-252. 
23. Thanassoulis, Emmanuel, Introduction to the theory and application of Data Envelopment Analysis: A 
foundation text with integrated software, Kluwer Academic Publishers, Boston/Dorecht/London, 2001. 
 
 
Appendix A 
 
Data Sources: 
 
OECD Annual Report, 2000. 
 
Life Expectancies:  
http://www.eurohealth.ie/newrep/demograph.htm, 
http://www.photius.com/wfb1999/rankings/life_expectancy_mf_1.html, and http://www.infoplease.com/cgi-
bin/id/A0005148.html; 
 
Infant Mortality: 
http://www.photius.com/wfb1997/canada/canada_people.html, 
http://www.photius.com/wfb1997/united_states/united_states_people.html; 
 
In-patient beds and Physicians, 1999: 
http://www.oecdwash.org/DATA/STATS/oecdinfig2002.pdf;  
 
School Life Expectancy:  
http://devdata.worldbank.org/edstats/query/ 
 
